NMOSD

7 drugs in development·4 companies·3 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
Ultomiris	Xencor Inc (XNCR)
uplizna	Viela Bio, Inc. (VIE)

Phase 4(5)

Drug	Company
Eculizumab	ENANTA PHARMACEUTICALS INC (ENTA)
Eculizumab administration	Valneva SE (VALN)
Inebilizumab	ENANTA PHARMACEUTICALS INC (ENTA)
Ravulizumab	ENANTA PHARMACEUTICALS INC (ENTA)
Satralizumab	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 7 drugs in development for NMOSD across 4 companies.

There are 3 clinical trials targeting NMOSD tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.